FTCM
XENT

First Trust Capital Management’s Intersect ENT, Inc XENT Stock Holding History

First Trust Capital Management’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-7,166
Closed -$201K – 459
2022
Q1 		$201K Buy
+7,166
New +$196K 0.02% 223

First Trust Capital Management's XENT Position: Q2 2022 in Review

First Trust Capital Management sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 7,166 shares — an estimated $201K sold.

First Trust Capital Management first reported a position in XENT in Q1 2022 and held it in 1 quarter. The position peaked at $201K in Q1 2022. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.

  • First Trust Capital Management reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
  • First Trust Capital Management sold 7,166 Intersect ENT, Inc shares in Q2 2022, an estimated $201K.
  • First Trust Capital Management first reported a position in Intersect ENT, Inc in Q1 2022 and held it in 1 quarter.
  • First Trust Capital Management's Intersect ENT, Inc position peaked at $201K in Q1 2022.
  • 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.

Based on First Trust Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.